The Health of Transmasculine Patients Compared With Cisgender Patients Treated With Hysterectomy in the U.S. South, 2014-2017

2014-2017年美国南部接受子宫切除术的跨性别男性患者与顺性别患者的健康状况比较

阅读:3

Abstract

This paper describes the clinical, reproductive, sociodemographic, and health care setting characteristics of a diverse transmasculine patient population compared to cisgender patients among a cohort treated with hysterectomy in a large health care system in the United States (US) South from 2014 to 2017. Additionally, we compare a computational phenotype (CP) for identifying transmasculine patients against a self-reported gender identity variable from the electronic health record (EHR). CPs are algorithms of medical codes and provider notes used to identify sub-populations not otherwise well-specified in EHR data. Without accurate identification of transgender patients, researchers are unable to fully address health issues in transgender populations. A CP for identifying transmasculine patients was generated using manual abstraction of provider notes, diagnostic codes, and prescription data. The CP identified 35 transmasculine hysterectomy patients compared to 1,822 cisgender women treated with hysterectomy for non-cancerous conditions. The 2017 EHR gender variable identified only 16 (45.7%) of the 35 patients from our CP method as transmasculine. Transmasculine patients (n=35) were younger and had higher reports of chronic pelvic pain than cisgender patients (n=1,822). Transmasculine patients were all treated in academic medical centers while cisgender patients were mostly treated at community hospitals. We found that an algorithm of diagnosis codes, keyword text-strings and testosterone prescriptions identified more transmasculine patients treated with hysterectomy than the self-reported gender identity variable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。